Search clinical trials for: Botulinum Toxin A

Total 10795 results

Allergan

Completed

Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence (LO-BOT)

Urinary Bladder, Overactive | Urinary Incontinence

United States
Ipsen

Completed

Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)

Lateral Canthal Lines

France, Germany, United Kingdom
Ipsen

Completed

Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis

Chronic Plantar Fasciitis

Germany
Ipsen

Completed

Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome

Myofascial Pain Syndromes

Italy, Spain, Portugal, Czechia, Germany, Poland
Ipsen

Completed

Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.

Cervical Dystonia

United States
Ipsen

Completed

Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm

Muscle Spasticity | Cerebrovascular Accident

Australia
Ipsen

Completed

A Study of the Combination of Electrical Stimulation and Dysport® in Myofascial Pain Syndrome.

Myofascial Pain Syndromes

Korea, Republic of
Ipsen

Completed

Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity

Muscle Spasticity | Cerebrovascular Accident

Hong Kong, Thailand, Malaysia, Philippines, Singapore
Ipsen

Completed

Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain

Low Back Pain

Korea, Republic of
Allergan

Completed

Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

France, Poland, Korea, Republic of, Canada, United States, Germany, Philippines, Czechia
Medy-Tox

Completed

Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy

Hypertrophy of Masseter Muscle

Korea, Republic of
Kocaeli University

Completed

Efficacy of Intermittent Serial Casting on Spastic Wrist Flexion Deformity

Cerebral Palsy

Turkey
Allergan

Completed

OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females

Depressive Disorder, Major

United States
Allergan

Completed

OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder (COMFORT)

Overactive Bladder

United States
University of California, Davis

Completed

The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis

Hyperhidrosis

United States
Medy-Tox

Completed

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

Essential Blepharospasm
Allergan

Completed

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

Overactive Bladder | Urinary Incontinence

Korea, Republic of
Shriners Hospitals for Children

Completed

Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery (BOLLD)

Lower Extremity Deformities, Congenital | Unequal Length of Limbs; Congenital

Canada, United States
Allergan

Completed

Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder

Canada, United States
Allergan

Terminated

Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

Spasmodic Torticollis

Argentina, India, Australia
Ivo Pitanguy Institute
Allergan

Completed

Radial Diffusion of the Botulinum Toxin Type A (Botox®): Electromyographic Evaluation of the Frontal Muscle

Wrinkles

Brazil
Merz Pharmaceuticals GmbH

Completed

IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity (NT-Spin)

Upper Limb Spasticity

France, Spain, Switzerland, United Kingdom, Italy, Austria, Germany, Portugal
National Institute of Diabetes and Digestive and...
George Washington University

Completed

Botulinum Toxin Injection for the Management of BPH (MIST2)

Benign Prostatic Hyperplasia

United States
Rick Hansen Institute
University of British Columbia; Vancouver Coastal Health; International Collaboration...

Completed

Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI

Autonomic Dysreflexia

Canada
Eisai Limited

Completed

An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects

Spasmodic Torticollis

Japan
Robert Jones and Agnes Hunt Orthopaedic and District...

Recruiting

Can Gait Analysis and Ultrasound Detect a Change in Calf Musculature in Children With Cerebral Palsy?

Cerebral Palsy

United Kingdom
Eirion Therapeutics Inc.

Active, not recruiting

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Crow's Feet | Lateral Canthal Lines, LCL

United States
Ipsen

Completed

Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression (ONTIME Pilot)

Stroke | Upper Limb Spasticity

Malaysia, Philippines, Singapore, Thailand
Ipsen

Terminated

Dysport in Vulvodynia Phase II Study (DYVINIA)

Vulvodynia

United States, Canada
Mayo Clinic
Allergan

Completed

Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

Neoplasms | Pain, Postoperative | Breast Cancer | Breast Diseases | BRCA1 Mutation | BRCA2 Mutation

United States
Allergan

Completed

Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

Multiple Sclerosis | Urinary Incontinence | Neurogenic Bladder

France, Poland, Portugal, Belgium, Canada, Russian Federation, Czechia, United States
Ankara University

Completed

Occlusal Splints or Botulinum Toxin?

Myofascial Pain | Temporomandibular Disorder

Turkey
Allergan

Terminated

A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation

Premature Ejaculation

United States, United Kingdom
Allergan

Completed

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Stroke | Cerebral Palsy | Muscle Spasticity | Pediatrics

United States, Korea, Republic of, Thailand, Hungary, Poland, Russian Federation, Turkey, Canada, Philippines
Innovaderm Research Inc.
Merz Pharmaceuticals GmbH

Completed

Treatment of Notalgia Paresthetica With Xeomin

Notalgia Paresthetica

Canada
University of California, Los Angeles
Allergan

Completed

Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome

Myofascial Pain Syndromes | Cervicobrachial Neuralgia

United States
Ipsen

Completed

A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants

Healthy Participants

United Kingdom
Karolinska Institutet

Completed

Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia

Vulvodynia

Sweden
Allergan

Completed

A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

Facial Rhytides

Canada
University of Nove de Julho
Daniela Aparecida Biasotto-Gonzalez; Claudia Santos Oliveira

Completed

Effect of Botulinum Toxin Type A Associated With Physical Therapy on Children With Spastic Cerebral Palsy

Physical Therapy | Cerebral Palsy, Spastic | Botulinum Toxin
Lanzhou Institute of Biological Products Co., Ltd

Unknown

A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migraine

Chronic Migraine
University Hospital, Rouen

Unknown

Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence (FI_TOXIN)

Fecal Incontinence

France
Eunice Kennedy Shriver National Institute of Child...

Terminated

Refractory Urge Incontinence and Botox Injections

Urinary Incontinence | Urinary Urgency | Urge Urinary Incontinence | Detrusor Overactivity

United States
Marmara University

Completed

Dynamic Lycra Orthosis as an Adjunct to Botulinum Toxin-A Injection for Post-stroke Spasticity

Stroke | Spasticity as Sequela of Stroke | Upper Limb Hypertonia

Turkey
Region Västerbotten
Umeå University

Recruiting

The Effect on Envelope of Motion in Asymptomatic Bruxers

Bruxism | Tooth Wear

Sweden
Allergan

Recruiting

Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

United States, Canada
All India Institute of Medical Sciences, New Delhi

Recruiting

Onabotulinum Toxin A (Botox) in the Treatment of Transfer Dysphagia

Oropharyngeal Dysphagia | Dysphagia, Late Effect of Stroke | Transfer Dysphagia | Cricopharyngeus Muscle Dysfunction

India
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; Merz Pharmaceuticals

Recruiting

Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) (BOTAF)

Cardiac Surgery

France
Stanford University
McCormick and Gabilan Faculty Fellowship Award

Active, not recruiting

Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome (T3STOPBPS)

Interstitial Cystitis | Bladder Pain Syndrome

United States
MTI University

Enrolling by invitation

Repetitive Transcranial Magnetic Stimulation Versus Botulinum Injection on Spasticity on Children With Diplegic Cerebral Palsy

Spastic Diplegic Cerebral Palsy

Egypt

Search clinical trials for: Botulinum Toxin A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations